The COVID-19 Pandemic Process Increase Latex Glove Use and Latex Allergy Complaints in Hospital Nurses? Survey Study (COVID19LATEX)

November 23, 2023 updated by: İslam Elagöz, Kilis 7 Aralik University

Background: Global guidelines recommend the use of personal protective equipment due to the high risk of contagiousness of COVID-19 disease. The increase in COVİD-19 patients in the last two years has increased the rate of use of latex gloves in nurses. It is not known how the increase in the use of latex gloves affects the complaints of latex allergy in nurses.

Aim: The aim of this study is to determine the rates of latex glove use and allergic complaints related to the use of latex gloves during the COVID-19 pandemic in hospital nurses.

Study Overview

Status

Completed

Detailed Description

Background: Global guidelines recommend the use of personal protective equipment due to the high risk of contagiousness of COVID-19 disease. The increase in COVİD-19 patients in the last two years has increased the rate of use of latex gloves in nurses. It is not known how the increase in the use of latex gloves affects the complaints of latex allergy in nurses.

Aim: The aim of this study is to determine the rates of latex glove use and allergic complaints related to the use of latex gloves during the COVID-19 pandemic in hospital nurses.

Materials and Methods: Ethical and legal permissions were obtained before starting the research. Research; It was conducted in a descriptive and cross-sectional manner at Hatay Training and Research Hospital between May 15 and June 15, 2021. The sample of the study consisted of 448 nurses who volunteered to participate in the study. The data of the study were collected with data collection forms created by the researchers as a result of literature reviews. The data of the research were collected by the online questionnaire method. Analysis of the data was analyzed with appropriate statistical methods in SPSS 21.0 program. p<0.05 value was accepted for statistical significance.

Study Type

Observational

Enrollment (Actual)

64

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kilis, Turkey, 79100
        • Islam

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The population of the study consisted of nurses working in Hatay Training and Research Hospital, and the sample consisted of nurses who met the inclusion criteria and volunteered to participate in the study. As a result of the research, 74.68% of the universe was reached. The sample size of the study was calculated in the G* Power 3.1.9.7 program, and a pyrori calculation was made according to the Mc Nemar test from the Exact test family. Cohen's d medium effect size was used in the calculation (Cohen J 1998). When the calculation is made such that odds ratio = 1.5, α error = 0.05, β error = 0.20, power = 0.80, effect size = 0.5 with the bidirectional hypothesis, the nurse to be sampled number was determined as N=398. The sample of the study (N=448) consisted of nurses.

Description

Inclusion Criteria:

  • Over 18 years old
  • Working as a nurse in Hatay Training and Research Hospital, Working in Hatay training and research hospital for the last month according to the date of the research
  • Nurses who volunteered to participate in the study were included in the study.

Exclusion Criteria:

  • Nurses who want to leave the study at any stage of the study after being included in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identifying Information Form:
Time Frame: 2023
The identifying information form consists of questions aimed at determining the age, gender, education status, department of work, nursing experience, experience in the last working department, glove selection, family history of atopy, personal history of atopy, crossfood allergies, latex glove usage, duration of glove use in a day, number of invasive procedures, presence of diagnosed latex allergy, measures taken to prevent latex allergy, awareness of nonlatex gloves, and complaints after contact with latex-containing products.
2023
Allergic Symptoms Evaluation Form:
Time Frame: 2023
The form consists of questions aimed at determining skin reactions and allergic symptoms such as itching, redness, swelling, hives, lesions, rash, contact dermatitis, swelling 7 around the mouth and throat, nasal discharge, itching, sneezing, itching, redness, watering of the eyes, shortness of breath, coughing, wheezing, fainting, feeling of faintness, loss of consciousness, thinking that existing symptoms are related to work, etc.
2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

August 1, 2021

Study Registration Dates

First Submitted

August 22, 2022

First Submitted That Met QC Criteria

August 24, 2022

First Posted (Actual)

August 25, 2022

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 23, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Allergy

3
Subscribe